| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |